by Pete Celano | May 19, 2025 | News
PBC is a form of liver disease that causes a backup of bile in your body. And it’s this buildup can trigger a reaction that irritates your peripheral nerves. What happens is the peripheral nerves then send sympathetic signals to the brain and trigger a need to...
by Pete Celano | May 15, 2025 | News
Big announcement on 05/14/2025: GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for up to $2 billion.GSK plc is a British multinational pharmaceutical and biotechnology company with headquarters in London. The firm was stablished in 2000 by a merger of...
by Brandon Tudor | May 13, 2025 | News
Women who experience menopause prior to the age of 50 are at increased risk of metabolic dysfunction-associated steatotic liver disease (MASLD), as well as coexisting risk factors such as prediabetes, obesity, high blood pressure, and abnormal lipid levels in the...
by Pete Celano | May 11, 2025 | News
The New England Journal of Medicine recently published a study titled “Efruxifermin in Compensated Liver Cirrhosis Caused by MASH” on May 7, 2025. This phase 3 clinical trial evaluated the efficacy and safety of efruxifermin, a fibroblast growth factor 21...
by Brandon Tudor | May 8, 2025 | News
In a study published in Nature, Keio University researchers unveiled a method to proliferate these hard-to-grow organoids by a million-fold in just 3–4 weeks while maintaining key liver functions. “These organoids are potentially the...
by Brandon Tudor | May 6, 2025 | News
Cedars-Sinai Scientists and Clinicians are presenting findings from 40 Studies of Digestive Diseases (list below). Presentations Cedars-Sinai investigators attending the conference are available to discuss their research covering many digestive disorders, including...
